Trump’s Push for U.S. Drug Manufacturing Expands to Pharma Ingredients With New Executive Order

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…

Read More

President Trump’s demand letter: What is he asking pharmaceutical companies to do?

On July 31, President Trump sent letters to some of the largest pharmaceutical companies in the world (AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi) asking them to fundamentally change drug pricing in the US. What was…

Read More

Few Trust Most Health Content on Social Media, Autism Claims Follow Thimerosal Policy Shift, and Misleading Narratives About SSRIs in Pregnancy — The Monitor

This volume analyzes findings from the latest KFF Tracking Poll on Health Information and Trust, which show that just over half of adults say they use social media to find health information and advice, but less than half trust the health content they see across an array of social media sites and apps. It also…

Read More

Few Trust Most Health Content on Social Media, Autism Claims Follow Thimerosal Policy Shift, and Misleading Narratives About SSRIs in Pregnancy — The Monitor

This volume analyzes findings from the latest KFF Tracking Poll on Health Information and Trust, which show that just over half of adults say they use social media to find health information and advice, but less than half trust the health content they see across an array of social media sites and apps. It also…

Read More